MNKD
NASDAQ · Biotechnology
Mannkind Corp
$3.52
-0.03 (-0.85%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+798.0% upside
Low Target
$20.51
Average Target
$31.61
High Target
$34.61
Current Price
$3.52
Current
$3.52
$3.52
Target
$31.61
$31.61
$20.51
$31.61 avg
$34.61
Scenario Analysis
Bear Case
$20.51
482.7%
Low target
Base Case
$31.61
+798.0%
Avg target
Bull Case
$34.61
+883.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$6.51
-45.9% from high
52-Week Low
$2.23
+57.8% from low
Target vs 52W High
$31.61
+385.6% vs high
Next Earnings Report
May 13, 2026 · After Market Close
2d
until earnings
EPS Est: $0.00
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |